These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16855336)

  • 1. Hemorrhagic bullae with nebulised ipratropium bromide.
    Saravanan V; Bankar RN; Kumar S; Williams JG
    J Postgrad Med; 2006; 52(3):235-6. PubMed ID: 16855336
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic unilateral mydriasis due to nebulized ipratropium bromide.
    Camkurt MA; Ay D; Akkucuk H; Ozcan H; Kunt MM
    Am J Emerg Med; 2011 Jun; 29(5):576.e5-6. PubMed ID: 20708871
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient anisocoria caused by aerosolized ipratropium bromide exposure from an ill-fitting face mask.
    Wehbe E; Antoun SA; Moussa J; Nassif I
    J Neuroophthalmol; 2008 Sep; 28(3):236-7. PubMed ID: 18769293
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease and hypertrophic obstructive cardiomyopathy: two antagonistic obstructions.
    Siniorakis E; Arvanitakis S; Pavlouros T; Batila T; Ntanos I; Rentoukas E
    Int J Cardiol; 2014 Oct; 176(3):e129-30. PubMed ID: 25125020
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhalation system on trial. Current feasibility study data].
    MMW Fortschr Med; 2006 Dec; 148(49-50):53. PubMed ID: 17619332
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angina bullosa haemorrhagica: associated steroid inhaler use.
    Poskitt L
    N Z Med J; 1991 Dec; 104(925):522. PubMed ID: 1758667
    [No Abstract]   [Full Text] [Related]  

  • 8. [Unilateral mydriasis of pharmacological origin].
    Martín Guerra JM; Iglesias Pérez C; Martín Asenjo M; Rodríguez Fernández L
    Rev Esp Geriatr Gerontol; 2019; 54(6):360. PubMed ID: 30598303
    [No Abstract]   [Full Text] [Related]  

  • 9. [Improved inhaler confirmed in general practice. Patients with respiratory diseases can breathe freely].
    MMW Fortschr Med; 2006 Dec; 148(49-50):52. PubMed ID: 17619331
    [No Abstract]   [Full Text] [Related]  

  • 10. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Angina bullosa haemorrhagica: a complication of long-term steroid inhaler use'.
    Porter K; Porter SR; Scully C
    Br Dent J; 1988 Oct; 165(8):279. PubMed ID: 3264178
    [No Abstract]   [Full Text] [Related]  

  • 13. Eye-opening Etiologies.
    Harer K; Alverson B
    Hosp Pediatr; 2018 May; 8(5):300-301. PubMed ID: 29650677
    [No Abstract]   [Full Text] [Related]  

  • 14. [Confusion and chorea triggered by the association of ipratropium bromide and salbutamol administered by inhaler].
    Rodríguez-Uranga JJ; Franco-Macías E; Sanz-Fernández G; Gil-Néciga E
    Rev Neurol; 2003 May 1-15; 36(9):900. PubMed ID: 12717681
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of inhaled ipratropium bromide on airway and lung tissue muscarinic receptors in a rat model of COPD].
    Yao W; Wang G; Zhu H; Zhao M
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):95-7. PubMed ID: 11820950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is nebulized ipratropium bromide effective in the treatment of exacerbations of chronic obstructive pulmonary disease?].
    Musil J
    Vnitr Lek; 2000 Jan; 46(1):45-8. PubMed ID: 10953664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inhalational bronchodilator treatment during noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations.
    Mukhopadhyay A; Dela Pena E; Wadden B; Procyshyn M; Keang Lim T
    J Crit Care; 2009 Sep; 24(3):474.e1-5. PubMed ID: 19664528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The validation and procedure of inhalation therapy using 2-component aerosols in obstructive bronchopulmonary diseases].
    Ivashkin VT; Iakovlev VN; Sinopal'nikov AI; Antokhin EA
    Ter Arkh; 1993; 65(8):44-9. PubMed ID: 8211802
    [No Abstract]   [Full Text] [Related]  

  • 19. [COPD treatment by drugs].
    Nafti S
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.